Shareholder Meetings

20242023202220212020201920182017
December 11th 2024June 20th 2024

December 11th 2024 General Meeting Documents

Notice of meeting – Bulletin des annonces légales obligatoires #133 (in french only)
Notice of meeting to the Ordinary and Extraordinary General Meeting (Form 6K)
Agenda and resolutions
Rapport du Conseil sur augmentation de capital – 11-10-2024
Rapport CACs – Augmentation Capital 11-10-2024
Rapport CACs – BSA – T1 – 11-10-2024
BoD Report to SGM
Statutory Auditors Report – Résolutions 5 à 22 (french only)
Statutory Auditors Report – Résolutions 23 à 32 (french only)
Statutory Auditors Report – Résolutions 33 à 48 (french only)
Statutory Auditors Report – Résolutions 49 à 57 (french only)
Statutory Auditors Report – Résolution 58 (french only)
Statutory Auditors Report – Résolution 59 (french only)
Statutory Auditors Report – Résolution 60 (french only)
Statutory Auditors Report – Résolution 61 (french only)
Statutory Auditors Report – Résolution 62 (french only)
Voting Form – SPECIMEN
Brochure
Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024
May 25th 2023January 25th 2023

May 25th 2023 General Meeting Review Documents

Results of the votes of the Combined Shareholders’ General Meeting of May 25, 2023

May 25th 2023 General Meeting Documents

Shareholders General Meeting (only in French)
Avis de réunion à l’Assemblée Générale Ordinaire et Extraordinaire du 25 mai 2023
Form 6-K notice of GM
Agenda and proposed resolutions
Number of shares and voting rights as at 17 April 2023
Availability of the preparatory documents
Rapport CaC sur réduction de capital
Report of BoD to the OEGM
Report of the BoD on the allocation of Free shares
Proxy card
Formulaire de vote
2022 aggregated 5 highest wages
Brochure

2021 General Meeting Review Documents

Results of the votes of the Combined Shareholders’ Meeting of April 16, 2021
Watch the replay of the Combined Shareholders’ Meeting of 16 April 2021
16-04-2021 – Assemblée Générale des Actionnaires (only in French)
16-04-2021 – Quorum général
16-04-2021 – Quorum par type
16-04-2021 – Résultats du vote
16-04-2021 – Arrêté de feuille de présence signée

2021 General Meeting Documents

Notice of meeting to the Ordinary and Extraordinary General Meeting dated April 16, 2021
Shareholders Meeting – Methods for participating and voting
Total voting rights and shares on March 10th, 2021
Rapport sur émission de BSA avec suppression du DPS au profit d’une catégorie de bénéficiaires
Rapport sur émission d’actions et diverses valeurs avec maintien et ou suppression DPS
Rapport sur émission actions ordinaires réservée aux adhérents d’un PEE
Rapport sur autorisation en vue d’attribuer gratuitement des actions aux membres du personnel
Rapport sur autorisation de souscriptions ou d’achats d’actions
Rapport sur la réduction du capital social
Additional Report of the Board of Directors – July 2020
Agenda and draft text of resolutions
Attestation rémunérations versées aux personnes mieux rémunérées en 2020
Attestation sur les dons à des fondations et oeuvre de mécénat en 2020
Formulaire de vote par correspondance – Huis Clos
General Meeting of Shareholders April 16, 2021 – Brochure
Rapport complémentaire du CAC sur augmentation de capital – 21 juillet 2020
Inventiva – URD 2020
Report of the Board of Directors to the General Meeting of Shareholders of April 16, 2021
Special report of the Board of Directors on the free allotments of shares – 2 March 2021
Notice of meeting to the Ordinary and Extraordinary General Meeting of April 16, 2021

Universal Registration Document

IVA Amendement URD - 10 2024
Regulated Information

Investor Contacts

Inventiva
50 rue de Dijon
21121 Daix, France
Email: finance@inventivapharma.com
Tel: +33 (0)3 80 44 75 00

Patti Bank
Managing Director
ICR Westwicke
Patti.Bank@westwicke.com
D 415-513-1284
San Francisco, CA
www.westwicke.com